Phase 4Status unknownAge-related condition

The efficacy and safety of metformin intervention in elderly overweight or obesity with mild cognitive impairment

Sponsor

Huadong Hospital, Fudan University

Enrollment

27 planned

Conditions

Overweight or obesity with mild cognitive impairment

Interventions

Take metformin sustained-release tablets orally (once a day, 1500mg each time; Diet and exercise for 26 weeks

Ages

adults, older adults

Registry

ChiCTR2600132779

Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed September 21, 2026